An end to the myth: there is no drug development pipeline.

An end to the myth: there is no drug development pipeline.

Item
http://www.wikidata.org/entity/Q38079806
Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discoveryNeglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationDisease advocacy organizations catalyze translational research.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?The role of brain tumor advocacy groups.Approaches to in vitro tissue regeneration with application for human disease modeling and drug development.Multicomponent Crystal Systems of Known Antimalarial Drug Molecules.Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational ResearchDerisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.Enabling Anyone to Translate Clinically Relevant Ideas to Therapies.Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.Current and Future Strategies for Improving Drug Discovery Efficiency
P2860

An end to the myth: there is no drug development pipeline.

Item
http://www.wikidata.org/entity/Q38079806
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An end to the myth: there is no drug development pipeline.
@en
type
label
An end to the myth: there is no drug development pipeline.
@en
prefLabel
An end to the myth: there is no drug development pipeline.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
An end to the myth: there is no drug development pipeline.
@en
P2093
P2860
P304
P31
P356
10.1126/SCITRANSLMED.3003505
P407
P433
P478
P50
P577
P5875
P698